BridgeBio Pharma, Inc. Restructuring Reserve, Current
BridgeBio Pharma, Inc. (BBIO) had Restructuring Reserve, Current of $6.99 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2026-02-24
- 2025-12-31: Restructuring Reserve, Current $6.99M.
- 2025-09-30: Restructuring Reserve, Current $3.35M.
- 2025-06-30: Restructuring Reserve, Current $526.00K.
- 2025-03-31: Restructuring Reserve, Current $1.01M.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2025-12-31 | $6.99M 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.35M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $526.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.01M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $1.85M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.37M 10-Q · filed 2025-10-29 |
| 2024-06-30 | $2.91M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $2.25M 10-Q · filed 2025-04-29 |
| 2023-12-31 | $55.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | $147.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $2.20M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $1.29M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $6.83M 10-K · filed 2026-02-24 |
| 2022-09-30 | $6.75M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $11.22M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $7.16M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $0.00 10-K · filed 2025-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |